Note 4 - Major Customers and Suppliers	9 Months Ended
Sep. 30, 2023
Notes to Financial Statements
Major Customers and Suppliers Disclosure [Text Block]	(4) MAJOR CUSTOMERS AND SUPPLIERS: Our revenues are derived primarily from chemical supply and pharmaceutical companies located primarily in the United States. For the three months ended September 30, 2023, two major customers accounted for 90% of total revenues. For the nine months ended September 30, 2023, three major customers accounted for 86% of total revenues. For the three months ended September 30, 2022, two customers accounting for 86% of total revenues. For the nine months ended September, 2022, three major customers accounted for 67% of total revenues. Substantially all inventory purchases were from four vendors in 2023 and 2022; however, the Company believes it can maintain purchases at similar levels through other readily available vendors in the marketplace. The Company maintains vendors both domestically and internationally. The Company has relationships with four laboratories that can manufacture our Aquaplex® line of products. There are multiple sources for our Trappsol® products. For the nine months ended September 30, 2023, the product mix of our revenues consisted of 99% basic natural and chemically modified cyclodextrins and 1% cyclodextrin complexes. For the three months ended September 30, 2023, the product mix of our revenues consisted entirely of basic natural and chemically modified cyclodextrins. For the three and nine months ended September 30, 2022 the product mix of our revenues consisted entirely of basic natural and chemically modified cyclodextrins.

Note 4 - Major Customers and Suppliers

9 Months Ended

Sep. 30, 2023

Major Customers and Suppliers Disclosure [Text Block]

(4) MAJOR CUSTOMERS AND SUPPLIERS:

Our revenues are derived primarily from chemical supply and pharmaceutical companies located primarily in the United States. For the three months ended September 30, 2023, two major customers accounted for 90% of total revenues. For the nine months ended September 30, 2023, three major customers accounted for 86% of total revenues. For the three months ended September 30, 2022, two customers accounting for 86% of total revenues. For the nine months ended September, 2022, three major customers accounted for 67% of total revenues.

Substantially all inventory purchases were from four vendors in 2023 and 2022; however, the Company believes it can maintain purchases at similar levels through other readily available vendors in the marketplace. The Company maintains vendors both domestically and internationally.

The Company has relationships with four laboratories that can manufacture our Aquaplex® line of products. There are multiple sources for our Trappsol® products.

For the nine months ended September 30, 2023, the product mix of our revenues consisted of 99% basic natural and chemically modified cyclodextrins and 1% cyclodextrin complexes. For the three months ended September 30, 2023, the product mix of our revenues consisted entirely of basic natural and chemically modified cyclodextrins. For the three and nine months ended September 30, 2022 the product mix of our revenues consisted entirely of basic natural and chemically modified cyclodextrins.